Calculus Capital (“Calculus”), pioneers of the tax efficient investment industry, is pleased to announce the successful sale of Mologic Limited (“Mologic” or “the Company”), a world leading innovator in lateral flow and rapid diagnostic technologies, and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

click here to read the full article

GET IN TOUCH!


  MAIL US
enquiries@growthinvest.com

  CALL US
020 7071 3945

FOLLOW US ON


Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.